Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.
D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004137:Dinitrochlorobenzene / Q000276:immunology; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007267:Injections; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged
D001500:BCG Vaccine; D004137:Dinitrochlorobenzene